Enfusion Inc Cl A (ENFN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 201,611 | 174,535 | 150,349 | 111,700 | 79,565 |
| Cost of Goods | 64,874 | 57,641 | 47,100 | 31,845 | 21,358 |
| Gross Profit | 136,737 | 116,894 | 103,249 | 79,855 | 58,207 |
| Operating Expenses | 131,456 | 105,587 | 115,313 | 356,584 | 52,491 |
| Operating Income | 6,155 | 11,948 | -11,964 | -275,884 | 6,074 |
| Interest Expense | -1,693 | -1,641 | -413 | 4,594 | 1,662 |
| Other Income | -459 | -2,105 | -638 | -1,185 | 82 |
| Pre-tax Income | 7,389 | 11,484 | -12,189 | -281,663 | 4,494 |
| Income Tax | 3,474 | 2,231 | 1,074 | 579 | 433 |
| Net Income Continuous | 3,915 | 9,253 | -13,263 | -282,242 | 4,061 |
| Minority Interests | 1,092 | 3,228 | -5,609 | -123,925 | N/A |
| Net Income | $2,823 | $6,025 | $-7,654 | $-158,317 | $4,061 |
| EPS Basic Total Ops | 0.03 | 0.07 | -0.10 | -2.26 | N/A |
| EPS Basic Continuous Ops | 0.04 | 0.10 | -0.16 | -3.40 | N/A |
| EPS Diluted Total Ops | 0.03 | 0.07 | -0.10 | -2.26 | N/A |
| EPS Diluted Continuous Ops | 0.03 | 0.07 | -0.16 | -3.40 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.06 | 0.09 | -0.10 | 0.55 | N/A |
| EBITDA(a) | $18,143 | $22,027 | $-5,594 | $-271,687 | $8,425 |